Trulieve Expands Cannabis Offerings in Florida and Texas with New Licensing Agreement

Trulieve Cannabis Corp. Secures Major Licensing Agreement

Trulieve Cannabis Corp. (NYSE: TRLV), a premier figure in the U.S. medical cannabis industry, has made headlines with its latest licensing agreement with Connected. Announced on September 28, 2026, this exclusive master licensing deal grants Trulieve the rights to genetics, trademarks, and proprietary knowledge necessary to cultivate and sell Alien Labs and Connected-branded cannabis products in two significant markets: Florida and Texas.

The agreement signifies a significant expansion for Trulieve, which has already been providing Alien Labs and Connected products in Florida since 2022. Under the new terms, Trulieve will maintain the critical quality standards established by Connected while capitalizing on the curated genetic offerings these brands are known for. Furthermore, this partnership allows Trulieve the opportunity to explore licensing in other markets in the future.

According to Trulieve CEO Kim Rivers, the company has continuously delighted customers in Florida with its premium cannabis strains and is now poised to broaden its offerings. Rivers remarked, “With this agreement, we plan to expand our premium product portfolio in Florida with new categories and form factors, further solidifying our leading market position.” Furthermore, they anticipate launching the Alien Labs and Connected products in Texas, pending necessary regulatory approvals.

Caleb Counts, the founder and CEO of Connected, expressed enthusiasm for the collaboration, emphasizing its success in the cannabis market. “Our partnership with Trulieve has become one of the most successful brand licensing relationships in cannabis,” he noted. “It’s proof of what’s possible when a legacy brand and a scaled operator play to each other’s strengths.”

Trulieve’s established platform not only provides access to the unique offerings of Alien Labs and Connected but also represents a gateway to some of the most premium cannabis genetics available nationwide. Counts highlighted that the products developed through Connected's proprietary breeding program are to be made available in both Florida and Texas, reflecting a significant step in their expansion strategy.

The partnership is set to include collaborative marketing campaigns aimed at promoting both brands, which will support their visibility across the states where they operate. This strategic move underlines Trulieve’s commitment to providing high-quality cannabis options to medical patients, ensuring they have access to unique and effective strains tailored to their needs.

As Trulieve pushes forward with its growth agenda, the backing of Connected is expected to bolster its product offerings and enhance its market positioning in the competitive landscape of cannabis. With Texas emerging as a pivotal market for cannabis, the potential for introducing top-tier products such as Alien Labs and Connected branded items makes this agreement a timely and impactful development for Trulieve.

For more information about the brands and products, customers can visit Alien Labs and Connected Cannabis.

As Trulieve moves ahead, stakeholders and investors are urged to stay informed of further developments as they unfold. The company maintains a transparent approach by disclosing risks associated with forward-looking statements, highlighting the ever-evolving nature of the cannabis market and its regulatory landscape.

For those interested in following Trulieve's journey, updates can be captured through various social media channels, including Facebook and Instagram. With a mission centered on enhancing patient access to cannabis, Trulieve is not only shaping the future of cannabis but also setting new standards for quality and service in the industry.